Ref 35f-1 - Positron Emission Tomography for Myocardial Viability
Positron Emission Tomography for Myocardial Viability
Reference No. | 35f |
| Reference Name | Positron Emission Tomography (PET) review: Myocardial Viability |
| Advisory Panel | Associate Professor Frederick Khafagi (Chair) (MSAC Member) Associate Professor John Atherton (MSAC member) (Cardiologist) Professor Brendon Kearney (Deputy Chair) (MSAC Member until 30/12/08) Professor Alex Pitman ANZAPNM Nominee Ms Anne Gracanin (Consumers’ Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | N/A |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | After considering the strength of the available evidence in relation to safety, effectiveness and cost-effectiveness, MSAC found that PET had no advantages in diagnostic accuracy or safety, and that the unit cost was up to three times greater, compared to other modalities for assessing myocardial viability in patients with moderate to severe left ventricular systolic dysfunction.
MSAC does not support the continuation of public funding for FDG PET for assessing myocardial viability in patients with moderate to severe left ventricular systolic dysfunction. |
| Stage 4 - Decision Noting of MSAC advice by the Minister does not constitute a final decision in relation to the provision of public funding. | MSAC considered this assessment on 29 March 2010 The Minister noted MSAC's advice 3 June 2010 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 06 July, 2010
